News & Events

Latest Symbiosis Newsletter is now Live

Three months have quickly passed since our last quarterly newsletter and much has been achieved. The Symbiosis team has significantly grown with the recruitment of two new highly skilled staff , we have attended Contract Pharma and BOS to name a few conferences, and we have been very busy in our cleanrooms manufacturing sterile pharmaceutical products for our increasing number of clients.

We also have many plans for the coming few months, including our upcoming exhibition at CPhI in Messe Frankfurt, Germany on the 22nd to 24th October. We have focused our newsletter this month around our visit to CPhI because we are keen to meet with both existing and potential clients at what is a major annual industry event. We have also included some exciting information about the Scotch whisky tasting event which Scottish Development International will be hosting as well as an open invitation to all to join us there for a ‘snifter’.

Have a look at our full newsletter and if you fancy joining us for a snifter or wish to arrange a meeting with us at CPhI to discuss fill finish or any lyophilization projects, feel free to send us an email to

…Hope to see you all at CPhI!

Symbiosis Pharmaceutical Services is a World Class specialist in the GMP sterile manufacture of liquid, lyophilized, cytotoxic, conventional and biological pharmaceuticals for clinical trials.

Get In Touch.

By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.